The ongoing Ebola outbreak in the Democratic Republic of the Congo has raised significant concerns, particularly due to the absence of an approved vaccine.
On May 18, 2026, experts began discussing the possibility of testing an unapproved vaccine that has not yet demonstrated its effectiveness.
This consideration reflects the urgent need for solutions in the face of a fast-growing health crisis, though the potential risks and benefits remain uncertain.